Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease

doi:10.3748/wjg.v20.i40.14950

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6657)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

263

WORD

206

HTML

3571

Figures (1-4)

266

Tables (1-2)

140

Sum=4446

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1107

Download

1104

Sum=2211

Oct 28, 2014 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Oct 28, 2014; 20(40): 14950-14957
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14950

Full Size Figure Download Figure

Figure 4 Insulin receptor mRNA expression in rat liver tissues of each group. Insulin receptor (IR) mRNA expression was assessed by RT-PCR analysis. The results are shown as a ratio of IR to β-actin based on densitometry analysis. The values are expressed as mean ± SD (n = 7). ^bP < 0.01 vs T2DM/NAFLD. NC: Normal control; T2DM: Type 2 diabetes mellitus; NAFLD: Nonalcoholic fatty liver disease; gAd: Globular adiponectin.

Citation: Ma H, Cui F, Dong JJ, You GP, Yang XJ, Lu HD, Huang YL. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(40): 14950-14957
URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14950.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14950